Advice
Parecoxib is not recommended for use within NHS Scotland.
RECOMMENDATION.
There is no evidence that the parenteral COX-2 selective non-steroidal anti-inflammatory drug (NSAID), parecoxib, is associated with a reduction in clinically significant post-operative haemorrhagic or gastro-intestinal complications compared with the non-selective NSAIDs. Parecoxib is substantially more expensive than non selective NSAIDs and should therefore not replace these drugs.
The license holder has indicated their decision to resubmit in light of additional information.
Download detailed advice18KB (PDF)
Medicine details
- Medicine name:
- Parecoxib (Dynastat®)
- SMC ID:
- 27/02
- Indication:
- Short-term treatment of postoperative pain
- Pharmaceutical company
- Pharmacia
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 10 January 2003